作者: Renée MF Ebisch , Albert G Siebers , Remko P Bosgraaf , Leon FAG Massuger , Ruud LM Bekkers
DOI: 10.1080/14737140.2016.1232166
关键词:
摘要: ABSTRACTIntroduction: High-risk human papillomavirus (hrHPV) testing is expected to replace cytology as primary screening method for cervical cancer in an increasing number of countries. The high sensitivity hrHPV combined with a limited specificity which makes triaging positive women necessary. As ideal triage does not yet exist, optimal strategy based on current knowledge should be obtained. aim this article present overview available options women, their strengths and limitations possible future opportunities.Areas covered: Current morphological biomarkers, molecular biomarkers strategies will discussed give the state-of-the-art women. literature search was studies women.Expert commentary: Experience morphology-based mak...